Bionomics IPO Presentation Deck

Powered by a Seasoned and Experienced Management Team Archemix Aventis BIODEL Bionomics Errol De Souza, PhD Executive Chairman Liz Doolin VP Clinical Development CATALYST BIOSCIENCES cyclerion Groumvent Pharma Deloitte. T Logos reflect experience in cument and/or post ros DUPONT IDEXX LABORATORIES LINK NOTHERAPEUTIC Connor Bernstein VP Strategy & Corporate Development Adrian Hinton Interim Chief Financial Officer Neurocrine PIPER SANDLER ROYALTY PHARMA RBC Capital Markets Synaptic NEUROPORE THERAPIES PALATIN Pharma Ltd. BOARD OF DIRECTORS ¹ Errol De Souza PhD Executive Chairman David Wilson Non-Executive Director Alan Fisher Non-Executive Director Jane Ryan PhD Non-Executive Director Mitchell Kaye BVF Nominee Aaron Weaver Apeiron Nominee Miles Davies Apeiron Nominee Bionomics Vpartners PiperJaffray Coopers &Lybrand ANATARA BCAL DEEP TRACK CAPITAL BVF APEIRON INVESTMENT GROUP atai A&O APEIRON INVESTMENT GROUP Rothschild & Co 5

View entire presentation